309 studies found for:    COATS DISEASE
Show Display Options
Rank Status Study
1 Completed Treatment of Congenital Telangiectasia (Coat's Disease) With Open-label Anecortave Acetate (15mg.)
Condition: Coat's Disease
Intervention: Drug: anecortave acetate
2 Completed Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related Maculopathy
Conditions: Coats' Disease;   Idiopathic Retinal Telangiectasia;   Retinal Angiomatous Proliferation;   Polypoidal Choroidal Vasculopathy;   Pseudoxanthoma Elasticum;   Pathological Myopia;   Multi-focal Choroiditis;   Rubeosis Iridis;   Von Hippel Lindau Disease;   BEST VITELLIFORM MACULAR DYSTROPHY, MULTIFOCAL (Disorder)
Intervention: Drug: ranibizumab injection (0.5 mg)
3 Completed Clinical Use of an Absorbable Coated Suture Material in Surgery (Safil)
Conditions: Gastrointestinal Diseases;   Laparotomy;   Anastomosis, Surgical;   Absorbable, Coated Sutures
Intervention: Procedure: Gastrointestinal Anastomosis
4 Recruiting Retinal Nerve Fiber Layer Thickness Changes in Parkinson Disease: A Meta-analysis
Condition: Parkinson Disease
Intervention: Device: Optical coherence tomography
5 Not yet recruiting Measurement of Retinal Nerve Fiber Layer Thickness - a Biomarker for the Early Detection of Alzheimer's Disease?
Condition: Alzheimer's Disease
6 Active, not recruiting Atherectomy Followed by a Drug Coated Balloon to Treat Peripheral Arterial Disease
Conditions: Peripheral Arterial Disease,;   Claudication
Interventions: Device: Cotavance Drug-Eluting Balloon;   Device: TurboHawk/SilverHawk Device followed by a Cotavance Drug-Eluting Balloon;   Device: TurboHawk/SilverHawk Device followed by a Cotavance Drug-Eluting Balloon (N=25)
7 Completed Intra-Individual Comparison of Sirolimus and Paclitaxel Coated Stent (FRE-RACE Study)
Condition: Coronary Artery Disease
Interventions: Device: Paclitaxel-eluting TAXUS(TM);   Device: Sirolimus eluting Cypher Select(TM)
8 Completed Paclitaxel Coated Balloon Catheter for Prevention of Restenosis in Femoropopliteal Arteries
Condition: Peripheral Arterial Disease
Intervention: Device: paclitaxel coated balloon catheter (device with drug)
9 Completed Effect of Paroxetine on COAT-Platelet Production in Normal Volunteers and Patients With Cardiovascular Disease
Condition: Coronary Artery Disease
Intervention: Drug: Paxil-CR
10 Completed A Randomized, Double-Blind, Controlled Study of the Safety and Performance of the NIRx™ Paclitaxel-Coated Conformer Coronary Stent
Condition: Coronary Artery Disease
Intervention: Device: NIRx(TM) Paclitaxel-Coated Conformer Coronary Stent System
11 Completed
Has Results
Enteric-coated Mycophenolate Sodium (EC-MPS) With Reduced-dose Tacrolimus Versus EC-MPS With Standard-dose Tacrolimus in Stable Kidney Transplant Recipients
Condition: Kidney Diseases
Interventions: Drug: Enteric-coated mycophenolate sodium (EC-MPS);   Drug: Tacrolimus;   Drug: Corticosteroids
12 Active, not recruiting Study of the Paclitaxel-Coated Balloon Catheter in Bifurcated Coronary Lesions
Condition: Coronary Artery Disease
Interventions: Procedure: Balloon angioplasty;   Procedure: Stent implantation
13 Recruiting Comparison of the Ranger™ Paclitaxel-Coated PTA Balloon Catheter and Uncoated PTA Balloons in Femoropopliteal Arteries
Conditions: Peripheral Artery Disease;   Claudication;   Atherosclerosis;   Arteriosclerosis
Interventions: Device: Ranger DCB;   Device: uncoated PTA balloon
14 Recruiting Bare Metal Stent Versus Drug Coated Balloon With Provisional Stenting in Non-ST-Elevation Myocardial Infarction
Conditions: Coronary Heart Disease;   NSTEMI
Interventions: Device: bare metal stent (BMS);   Device: SeQuent(R) Please coated balloon
15 Recruiting Atherectomy and Drug-Coated Balloon Angioplasty in Treatment of Long Infrapopliteal Lesions
Conditions: Peripheral Artery Disease;   Occlusion of Artery
Interventions: Procedure: paclitaxel-coated balloon angioplasty;   Procedure: atherectomy
16 Completed Paclitaxel-coated Balloons in Femoral Indication to Defeat Restenosis
Condition: Peripheral Artery Disease
Intervention: Procedure: Percutaneous transluminal angioplasty (PTA)
17 Completed Chest Wall Oscillation for Asthma and COPD Exacerbations Trial (COAT)
Conditions: Asthma;   Chronic Obstructive Pulmonary Disease (COPD);   Undifferentiated Asthma/COPD
Intervention: Device: High Frequency Chest Wall Oscillator
18 Unknown  Stenting With or Without Coating Compared With Angioplasty in Non-benestent Disease
Condition: Coronary Artery Disease
Intervention: Device: Bx Sonic & Cypher stent from Cordis
19 Enrolling by invitation Mobilization of Endothelial Progenitor Cells Induced by Atorvastatin in Patients With Stable Coronary Artery Disease Treated With Anti-CD 34 Antibodies Coated Stents
Condition: Stable Coronary Artery Disease
Intervention: Drug: Atorvastatin
20 Active, not recruiting Treatment of Coronary Artery Disease (CAD) With Bare Metal Stent (BMS) Followed by Paclitaxel-Coated Balloon Catheter Versus Paclitaxel-Eluting Stent
Condition: Coronary Artery Disease
Interventions: Device: Coroflex Blue (BMS) followed by SeQuent Please (DEB);   Device: Coroflex Please (DES)

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years